Medications for Major Depressive Disorder

14 results
  • abilify - aripiprazole tablet

    (Aripiprazole)
    Otsuka America Pharmaceutical, Inc.
    Abilify (aripiprazole) is indicated for schizophrenia, acute manic and mixed episodes of Bipolar I Disorder, adjunctive treatment of major depressive disorder, irritability associated with autistic disorder, and Tourette's Disorder.
  • aplenzin - bupropion hydrobromide tablet, extended release

    (Bupropion Hydrobromide)
    Bausch Health Us, Llc
    Aplenzin treats major depressive disorder (MDD) in adults and prevents seasonal major depressive episodes in patients with seasonal affective disorder (SAD).
  • caplyta - lumateperone capsule

    (Lumateperone)
    Intra-Cellular Therapies, Inc
    Caplyta treats schizophrenia in adults, depressive episodes associated with bipolar I or II disorder (as monotherapy or adjunctive therapy with lithium or valproate), and major depressive disorder as adjunctive therapy with antidepressants.
  • fetzima - levomilnacipran hydrochloride capsule, extended release

    (Levomilnacipran Hydrochloride)
    Allergan, Inc.
    Fetzima is indicated for the treatment of major depressive disorder (MDD) in adults. It is not approved for the management of fibromyalgia.
  • rexulti - brexpiprazole tablet

    (Brexpiprazole)
    Otsuka America Pharmaceutical, Inc.
    REXULTI is used as add-on therapy with antidepressants for major depressive disorder in adults, treats schizophrenia in adults and adolescents 13 and older, and manages agitation from Alzheimer's-related dementia. Not approved for as-needed use.
  • spravato - esketamine hydrochloride solution

    (Esketamine Hydrochloride)
    Janssen Pharmaceuticals Inc.
    Spravato treats treatment-resistant depression (TRD) in adults, alone or with an oral antidepressant. It also treats depressive symptoms in adults with major depressive disorder (MDD) and acute suicidal ideation or behavior, used alongside an oral antidepressant.